Show simple item record

Biomedical Innovation and the Politics of Scientific Knowledge: A case study of Gardasil

dc.contributor.advisorMamo, Lauraen_US
dc.contributor.authorClark, Aleia Yvonneen_US
dc.description.abstractVaccine development represents a special case where historically, public health priorities are central. Trends of privatization have increased the role played by pharmaceutical and biotech companies in developing new biomedical technologies. As the innovative science behind new medical technologies moves into pharmaceutical laboratories and biotech companies, the "logics of action" that pattern knowledge production shift. This project explores how different logics of action based on commercial investment and public good shaped the development of Gardasil, a new vaccine to prevent cervical cancer. The study found that both the logics of public good and commercial profit significantly shaped the final product. The study also found that variations in the definition of public good allowed for the settlement of tensions between good and profit. The findings have implications for the future of vaccine development, as well as for the analysis of biomedical innovation in our contemporary political economy.en_US
dc.format.extent806580 bytes
dc.titleBiomedical Innovation and the Politics of Scientific Knowledge: A case study of Gardasilen_US
dc.contributor.publisherDigital Repository at the University of Marylanden_US
dc.contributor.publisherUniversity of Maryland (College Park, Md.)en_US
dc.subject.pqcontrolledSociology, Generalen_US
dc.subject.pqcontrolledHealth Sciences, Public Healthen_US
dc.subject.pqcontrolledBiology, Virologyen_US
dc.subject.pquncontrolledhuman papillomavirusen_US
dc.subject.pquncontrolledpharmaceutical industryen_US

Files in this item


This item appears in the following Collection(s)

Show simple item record